Evaluation of the safety of C-1311 (SYMADEX) administered in a phase 1 dose escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumoursNicolás Isambert, P. Fumoleau, Mario Campone et al.|European Journal of Cancer|2009Cited by 45
Prognostic factors and outcomes of adult spermatic cord sarcoma. A study from the French Sarcoma GroupGilles Achard, Nicolás Isambert, Céline Charon‐Barra et al.|European Journal of Surgical Oncology|2023Cited by 6
Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma GroupPascaline Boudou‐Rouquette, Nicolás Isambert, Esma Saâda-Bouzid et al.|International Journal of Cancer|2021Cited by 3
Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancerMarina Elena Cazzaniga, Maureen Trudeau, Foluso O. Ademuyiwa et al.|JNCI Cancer Spectrum|2023Cited by 3
Neoadjuvant chemotherapy associated with enhanced local control in radiation-induced angiosarcoma of breast and chestAudrey Michot, Eberhard Stoeckle, Antoine GIraud et al.|European Journal of Surgical Oncology|2023Cited by 1